通过智能手机应用程序和智能手环收集的乳腺癌幸存者身体活动数据的评估卡塔尔世界杯8强波胆分析观察研究%A Chung, A Yong, A Jung,Miyeon， %A Lee, se byl %A Lee,Jong Won, A Park,Yu Rang, A Cho,Daegon, A Chung,Haekwon, A yun,Soyoung, A Min,Yul Ha, A Park,Hye Jin, A Lee,Minsun, A Chung, seockon, A Son,Byung Ho, A Ahn,Sei-Hyun，外科，蔚山大学医学院，88，奥林匹克43号，首尔松坡区，05505，韩国，82 107204620，newstar153@hanmail.net %K远程医疗%K乳腺肿瘤%K移动应用%K生活质量%K压力、心理%K患者依从性%K智能手机%K手机%K可穿戴电子设备%K生存率%D 2019 %7 06.09.2019 %9背景:尽管窘迫筛查对癌症幸存者至关重要，但临床医生不易识别出窘迫。通过智能手环和智能手机应用等移动设备收集的身体活动(PA)数据有可能用于筛查乳腺癌幸存者的痛苦。目的:本研究的目的是评估智能手机app和智能手环在PA数据方面的数据收集率，研究移动设备的PA数据与智能手机app的痛苦相关问卷之间的相关性，并论证智能手环和智能手机app在乳腺癌幸存者中收集数据的相关因素。方法:在这项前瞻性观察研究中，2017年6月至2018年3月期间在韩国首尔牙山医疗中心接受乳腺癌手术的患者被招募，并被要求使用智能手机应用程序和智能手环6个月。通过智能手机步行应用程序和可穿戴智能手环收集每日PA数据的总体依从率以受试者内的方式进行分析。计算纵向每日收集率以检查辍学模式。我们还进行了多变量线性回归分析，以检查与每日收集依从性相关的因素。最后，我们使用Pearson相关分析检验了日平均步数与痛苦程度之间的相关性。 Results: A total of 160 female patients who underwent breast cancer surgeries were enrolled. The overall compliance rates for using a smartphone app and smart bands were 88.0% (24,224/27,513) and 52.5% (14,431/27,513), respectively. The longitudinal compliance rate for smartphone apps was 77.8% at day 180, while the longitudinal compliance rate for smart bands rapidly decreased over time, reaching 17.5% at day 180. Subjects who were young, with other comorbidities, or receiving antihormonal therapy or targeted therapy showed significantly higher compliance rates to the smartphone app. However, no factor was associated with the compliance rate to the smart band. In terms of the correlation between the count of daily steps and distress level, step counts collected via smart band showed a significant correlation with distress level. Conclusions: Smartphone apps or smart bands are feasible tools to collect data on the physical activity of breast cancer survivors. PA data from mobile devices are correlated with participants’ distress data, which suggests the potential role of mobile devices in the management of distress in breast cancer survivors. Trial Registration: ClinicalTrials.gov NCT03072966; https://clinicaltrials.gov/ct2/show/NCT03072966 %M 31493319 %R 10.2196/13463 %U //www.mybigtv.com/2019/9/e13463 %U https://doi.org/10.2196/13463 %U http://www.ncbi.nlm.nih.gov/pubmed/31493319